Picture of Divi's Laboratories logo

DIVISLAB Divi's Laboratories Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Annual cashflow statement for Divi's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line18,55118,19526,66036,83523,686
Depreciation
Non-Cash Items-854-1,262-663-718-1,982
Unusual Items
Other Non-Cash Items
Changes in Working Capital-9,843-6,635-9,084-20,114-538
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities9,54312,15919,46919,11824,597
Capital Expenditures-7,331-11,832-9,102-7,132-4,730
Purchase of Fixed Assets
Other Investing Cash Flow Items47710,9979,853-14,817-22,346
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6,854-835751-21,949-27,076
Financing Cash Flow Items-35-61-8.7-3.6-3.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,459-10,914-349-5,324-7,972
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash23041119,872-8,156-10,451